AtriCure EBITDA vs. Number Of Shares Shorted
| ATRC Stock | USD 42.41 0.64 1.53% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -16.7 M | Current Value -15.8 M | Quarterly Volatility 21.6 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.58 | 0.67 |
|
|
For AtriCure profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AtriCure to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AtriCure utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AtriCure's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AtriCure over time as well as its relative position and ranking within its peers.
Check out Trending Equities. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 0.158 | Return On Assets | Return On Equity |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AtriCure Number Of Shares Shorted vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AtriCure's current stock value. Our valuation model uses many indicators to compare AtriCure value to that of its competitors to determine the firm's financial worth. AtriCure is number one stock in ebitda category among its peers. It also is number one stock in number of shares shorted category among its peers . At present, AtriCure's EBITDA is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AtriCure's earnings, one of the primary drivers of an investment's value.AtriCure's Earnings Breakdown by Geography
AtriCure Number Of Shares Shorted vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
AtriCure |
| = | (18.53 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
AtriCure |
| = | 2.5 M |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
AtriCure Number Of Shares Shorted Comparison
AtriCure is currently under evaluation in number of shares shorted category among its peers.
AtriCure Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AtriCure, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AtriCure will eventually generate negative long term returns. The profitability progress is the general direction of AtriCure's change in net profit over the period of time. It can combine multiple indicators of AtriCure, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -931.5 K | -884.9 K | |
| Operating Income | -36 M | -34.2 M | |
| Total Other Income Expense Net | -3.3 M | -3.1 M | |
| Net Loss | -40.2 M | -38.2 M | |
| Income Tax Expense | 921.6 K | 868.4 K | |
| Income Before Tax | -39.3 M | -37.3 M | |
| Net Loss | -40.2 M | -38.2 M | |
| Non Operating Income Net Other | 1.7 M | 1.8 M | |
| Net Loss | -41.8 M | -39.7 M | |
| Interest Income | 5.1 M | 5.4 M | |
| Net Interest Income | -1.8 M | -1.9 M | |
| Change To Netincome | 26.6 M | 27.9 M | |
| Net Loss | (0.86) | (0.90) | |
| Income Quality | (0.17) | (0.16) | |
| Net Income Per E B T | 1.18 | 1.11 |
AtriCure Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AtriCure. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AtriCure position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AtriCure's important profitability drivers and their relationship over time.
AtriCure Earnings Estimation Breakdown
The calculation of AtriCure's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of AtriCure is estimated to be -0.1071 with the future projection ranging from a low of -0.16 to a high of -0.06. Please be aware that this consensus of annual earnings estimates for AtriCure is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.16 Lowest | Expected EPS | -0.06 Highest |
AtriCure Earnings Projection Consensus
Suppose the current estimates of AtriCure's value are higher than the current market price of the AtriCure stock. In this case, investors may conclude that AtriCure is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and AtriCure's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 9 | 51.53% | 0.0 | -0.1071 | -0.61 |
AtriCure Earnings per Share Projection vs Actual
Actual Earning per Share of AtriCure refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering AtriCure predict the company's earnings will be in the future. The higher the earnings per share of AtriCure, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.AtriCure Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as AtriCure, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of AtriCure should always be considered in relation to other companies to make a more educated investment decision.AtriCure Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact AtriCure's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-10-29 | 2025-09-30 | -0.11 | -0.01 | 0.1 | 90 | ||
2025-07-28 | 2025-06-30 | -0.167 | -0.02 | 0.147 | 88 | ||
2025-04-29 | 2025-03-31 | -0.2234 | -0.14 | 0.0834 | 37 | ||
2025-02-13 | 2024-12-31 | -0.1488 | -0.08 | 0.0688 | 46 | ||
2024-10-29 | 2024-09-30 | -0.19 | -0.17 | 0.02 | 10 | ||
2024-07-30 | 2024-06-30 | -0.17 | -0.17 | 0.0 | 0 | ||
2024-05-01 | 2024-03-31 | -0.23 | -0.28 | -0.05 | 21 | ||
2024-02-15 | 2023-12-31 | -0.23 | -0.21 | 0.02 | 8 | ||
2023-11-01 | 2023-09-30 | -0.31 | -0.2 | 0.11 | 35 | ||
2023-07-25 | 2023-06-30 | -0.3 | -0.11 | 0.19 | 63 | ||
2023-05-02 | 2023-03-31 | -0.34 | -0.23 | 0.11 | 32 | ||
2023-02-21 | 2022-12-31 | -0.18 | -0.09 | 0.09 | 50 | ||
2022-11-01 | 2022-09-30 | -0.25 | -0.27 | -0.02 | 8 | ||
2022-08-02 | 2022-06-30 | -0.29 | -0.32 | -0.03 | 10 | ||
2022-05-03 | 2022-03-31 | -0.32 | -0.33 | -0.01 | 3 | ||
2022-02-15 | 2021-12-31 | -0.29 | -0.3 | -0.01 | 3 | ||
2021-11-03 | 2021-09-30 | -0.32 | 2.11 | 2.43 | 759 | ||
2021-08-04 | 2021-06-30 | -0.33 | -0.36 | -0.03 | 9 | ||
2021-04-27 | 2021-03-31 | -0.37 | -0.38 | -0.01 | 2 | ||
2021-02-23 | 2020-12-31 | -0.28 | -0.28 | 0.0 | 0 | ||
2020-11-05 | 2020-09-30 | -0.34 | -0.11 | 0.23 | 67 | ||
2020-07-28 | 2020-06-30 | -0.57 | -0.2 | 0.37 | 64 | ||
2020-04-29 | 2020-03-31 | -0.41 | -0.42 | -0.01 | 2 | ||
2020-02-18 | 2019-12-31 | -0.41 | -0.42 | -0.01 | 2 | ||
2019-10-30 | 2019-09-30 | -0.27 | -0.25 | 0.02 | 7 | ||
2019-07-30 | 2019-06-30 | -0.18 | -0.11 | 0.07 | 38 | ||
2019-04-25 | 2019-03-31 | -0.24 | -0.15 | 0.09 | 37 | ||
2019-02-28 | 2018-12-31 | -0.17 | -0.09 | 0.08 | 47 | ||
2018-11-01 | 2018-09-30 | -0.22 | -0.22 | 0.0 | 0 | ||
2018-08-01 | 2018-06-30 | -0.23 | -0.19 | 0.04 | 17 | ||
2018-04-26 | 2018-03-31 | -0.27 | -0.31 | -0.04 | 14 | ||
2018-02-26 | 2017-12-31 | -0.21 | -0.2 | 0.01 | 4 | ||
2017-11-01 | 2017-09-30 | -0.24 | -0.22 | 0.02 | 8 | ||
2017-07-27 | 2017-06-30 | -0.26 | -0.21 | 0.05 | 19 | ||
2017-05-04 | 2017-03-31 | -0.35 | -0.32 | 0.03 | 8 | ||
2017-02-28 | 2016-12-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2016-10-27 | 2016-09-30 | -0.28 | -0.21 | 0.07 | 25 | ||
2016-08-04 | 2016-06-30 | -0.3 | -0.26 | 0.04 | 13 | ||
2016-04-28 | 2016-03-31 | -0.32 | -0.31 | 0.01 | 3 | ||
2016-02-23 | 2015-12-31 | -0.34 | -0.36 | -0.02 | 5 | ||
2015-10-27 | 2015-09-30 | -0.22 | -0.22 | 0.0 | 0 | ||
2015-07-28 | 2015-06-30 | -0.21 | -0.18 | 0.03 | 14 | ||
2015-04-29 | 2015-03-31 | -0.21 | -0.19 | 0.02 | 9 | ||
2015-02-23 | 2014-12-31 | -0.2 | -0.2 | 0.0 | 0 | ||
2014-10-30 | 2014-09-30 | -0.17 | -0.02 | 0.15 | 88 | ||
2014-07-24 | 2014-06-30 | -0.19 | -0.2 | -0.01 | 5 | ||
2014-04-24 | 2014-03-31 | -0.22 | -0.21 | 0.01 | 4 | ||
2014-02-27 | 2013-12-31 | -0.14 | -0.24 | -0.1 | 71 | ||
2013-10-29 | 2013-09-30 | -0.15 | -0.13 | 0.02 | 13 | ||
2013-08-01 | 2013-06-30 | -0.1 | -0.09 | 0.01 | 10 | ||
2013-05-02 | 2013-03-31 | -0.11 | -0.1 | 0.01 | 9 | ||
2013-02-28 | 2012-12-31 | -0.1 | -0.12 | -0.02 | 20 | ||
2012-11-01 | 2012-09-30 | -0.12 | -0.16 | -0.04 | 33 | ||
2012-08-02 | 2012-06-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2012-05-02 | 2012-03-31 | -0.14 | -0.1 | 0.04 | 28 | ||
2012-02-27 | 2011-12-31 | -0.07 | -0.13 | -0.06 | 85 | ||
2011-11-01 | 2011-09-30 | -0.08 | -0.07 | 0.01 | 12 | ||
2011-08-02 | 2011-06-30 | -0.05 | -0.06 | -0.01 | 20 | ||
2011-05-04 | 2011-03-31 | -0.07 | -0.08 | -0.01 | 14 | ||
2011-02-16 | 2010-12-31 | -0.07 | 8.0E-4 | 0.0708 | 101 | ||
2010-11-02 | 2010-09-30 | -0.1 | -0.07 | 0.03 | 30 | ||
2010-08-04 | 2010-06-30 | -0.12 | -0.05 | 0.07 | 58 | ||
2010-05-10 | 2010-03-31 | -0.1 | -0.13 | -0.03 | 30 | ||
2010-02-18 | 2009-12-31 | -0.09 | -0.15 | -0.06 | 66 | ||
2009-11-04 | 2009-09-30 | -0.1 | -0.06 | 0.04 | 40 | ||
2009-08-04 | 2009-06-30 | -0.08 | -0.1 | -0.02 | 25 | ||
2009-05-05 | 2009-03-31 | -0.19 | -0.08 | 0.11 | 57 | ||
2009-02-19 | 2008-12-31 | -0.18 | -0.22 | -0.04 | 22 | ||
2008-11-04 | 2008-09-30 | -0.15 | -0.12 | 0.03 | 20 | ||
2008-08-05 | 2008-06-30 | -0.17 | -0.11 | 0.06 | 35 | ||
2008-05-06 | 2008-03-31 | -0.22 | -0.25 | -0.03 | 13 | ||
2008-02-14 | 2007-12-31 | -0.2 | -0.11 | 0.09 | 45 | ||
2007-11-06 | 2007-09-30 | -0.26 | -0.18 | 0.08 | 30 | ||
2007-08-09 | 2007-06-30 | -0.27 | -0.22 | 0.05 | 18 | ||
2007-05-10 | 2007-03-31 | -0.29 | -0.35 | -0.06 | 20 | ||
2007-02-15 | 2006-12-31 | -0.43 | -0.35 | 0.08 | 18 | ||
2006-11-08 | 2006-09-30 | -0.4 | -0.26 | 0.14 | 35 | ||
2006-08-08 | 2006-06-30 | -0.34 | -0.26 | 0.08 | 23 | ||
2006-05-04 | 2006-03-31 | -0.36 | -0.24 | 0.12 | 33 | ||
2006-02-16 | 2005-12-31 | -0.31 | -0.33 | -0.02 | 6 | ||
2005-11-03 | 2005-09-30 | -0.33 | -0.5 | -0.17 | 51 |
Use AtriCure in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AtriCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will appreciate offsetting losses from the drop in the long position's value.AtriCure Pair Trading
AtriCure Pair Trading Analysis
The ability to find closely correlated positions to AtriCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AtriCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AtriCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AtriCure to buy it.
The correlation of AtriCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AtriCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AtriCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AtriCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your AtriCure position
In addition to having AtriCure in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Apparel Thematic Idea Now
Apparel
Companies manufacturing textile accessories and apparel products. The Apparel theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
To fully project AtriCure's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AtriCure at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AtriCure's income statement, its balance sheet, and the statement of cash flows.